Gaucher Disease Pharmaceutical, Drug and Healthcare Pipeline Review H2
Feb 22, 2017
WiseGuyReports.com adds Exclusive Research on “Gaucher Disease - Pipeline Review, H1 2016” reports to its database.
Pune, India - February 22, 2017 /MarketersMedia/ —
The report provides comprehensive information on the therapeutics under development for Gaucher Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Gaucher Disease and features dormant and discontinued projects.
GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/543761-gaucher-disease-pipeline-review-h1-2016
Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Scope
- The report provides a snapshot of the global therapeutic landscape of Gaucher Disease
- The report reviews pipeline therapeutics for Gaucher Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Gaucher Disease therapeutics and enlists all their major and minor projects
- The report assesses Gaucher Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Gaucher Disease
Reasons to buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Gaucher Disease
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Gaucher Disease pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Content: Key Points
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Gaucher Disease Overview 9
Therapeutics Development 10
Pipeline Products for Gaucher Disease - Overview 10
Pipeline Products for Gaucher Disease - Comparative Analysis 11
Gaucher Disease - Therapeutics under Development by Companies 12
Gaucher Disease - Therapeutics under Investigation by Universities/Institutes 13
Gaucher Disease - Pipeline Products Glance 14
Clinical Stage Products 14
Early Stage Products 15
Gaucher Disease - Products under Development by Companies 16
Gaucher Disease - Products under Investigation by Universities/Institutes 17
Gaucher Disease - Companies Involved in Therapeutics Development 18
Actelion Ltd 18
Bioorganic Research and Services S.A. 19
Genzyme Corporation 20
greenovation Biotech GmbH 21
JCR Pharmaceuticals Co., Ltd. 22
Lixte Biotechnology Holdings, Inc. 23
Neuraltus Pharmaceuticals, Inc. 24
…Continued
ACCESS REPORT @ https://www.wiseguyreports.com/reports/543761-gaucher-disease-pipeline-review-h1-2016
Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028 Maharashtra, India
Phone: +1-646-845-9349
Source URL: http://marketersmedia.com/gaucher-disease-pharmaceutical-drug-and-healthcare-pipeline-review-h2/172230
For more information, please visit http://www.wiseguyreports.com
Source: MarketersMedia
Release ID: 172230
More News
Spanish firm set to buy Harland and Wolff
Spain’s state-owned shipbuilder Navantia is in exclusive talks to buy the Belfast-based shipyard.
Cyber wars and global collaboration: Huawei executive on cybersecurity
"Cybersecurity is no longer a weapon of mass disruption but of mass destruction, because it can kill lives," said Aloysius Cheang, Huawei's president of Cybersecurity & Privacy Protection and chief security officer for the Middle East and Central Asia, stressing the increasingly dangerous nature of cyberattacks.
China's economy shows stable overall performance
China's economy has continued to improve and made steady progress in high-quality development, amidst a complex and ever-evolving international landscape.
China's yuan loans grow by 16.02 trillion yuan in first 3 quarters
China's yuan-denominated loans rose by 16.02 trillion yuan (about $2.27 trillion) in the first three quarters of the year. The M2, a broad measure of money supply that covers cash in circulation and all deposits, climbed 6.8 percent year on year to 309.48 trillion yuan at the end of September.
China to enhance catalytic role of government investment
On September 26, the Political Bureau of the Central Committee of the Communist Party of China convened a meeting to analyze the current economic situation and outline the next steps for economic work. This meeting not only signaled a shift in China's macroeconomic policy but also showed the country's confidence in achieving its annual economic and social development goals, rallying the entire society to drive sustained economic recovery and improvement.
Ensuring rule-based high-quality development of the private sector
A draft law on China's private sector promotion was released to solicit public opinions last week, marking a significant milestone in the construction of a law-based business environment in China.
How Kamala Harris’s Economic Plan Has Been Shaped by Business Leaders
The vice president has repeatedly incorporated suggestions from business executives into her economic agenda.
China’s Stock Markets Rebound on Promises to Help Businesses
Assurances from government officials on plans to strengthen the private sector offset a lack of specifics about economic stimulus.
China reports 5.3% growth in foreign trade over first three quarters
China's foreign trade surged robustly in the first three quarters of 2024, surpassing the 32 trillion yuan ($4.44 trillion) mark for the first time during this period.
‘I lost £165k to fraud in an hour’ - customers say they were let down by Revolut
Revolut was named in more complaints about fraud last year than any of the UK’s biggest banks or e-money services.
TSMC 3rd-quarter profit to jump by 40% amid rising chip demand
TSMC 3rd-quarter profit to jump by 40% amid rising chip demand
John F. Kennedy Jr.’s 1990s-Era Magazine Is Back, With a QAnon Twist
It is a reanimation story strange enough for a zombie movie, made possible by the fact that the original George trademark lapsed, only to be secured by a conservative lawyer.
Evan Gershkovich, U.S. Journalist Imprisoned in Russia, Will Publish a Memoir
The memoir, which will cover his time in prison and Russia’s move toward autocracy, will be published by Crown, an imprint of Penguin Random House.
Dreaming of diamonds: Generations dig for fortune in India's gem town
In Panna, families hunt for diamonds hoping to strike rich and escape the cycle of poverty.
Thousands of cars that crash in US are ending up in Russia
The South Caucasus nation of Georgia has a huge used car market, with many vehicles finding their way over the border.
The Secretive Dynasty That Controls the Boar’s Head Brand
The deli-meat company made its owners fabulously wealthy. But they have remained silent, even as the company faces the biggest scandal in its history.
Watch: Why is the latest SpaceX rocket test a big deal?
The BBC's Pallab Ghosh explores why this world first test is a big deal for space exploration.
Fisher-Price Recalls ‘Snuga Swings’ Linked to Five Infant Deaths
The U.S. Consumer Product Safety Commission announced the recall, which one of its commissioners said was “doomed to fail.”
How Roger Goodell Made the NFL the World’s Wealthiest Sports League
Under the expansionist leadership of its commissioner, the National Football League is growing richer and richer. So, too, is Mr. Goodell.
Pakistan hosting SCO meeting is a turning point for regional diplomacy
Pakistan hosting SCO meeting is a turning point for regional diplomacy
Executives and Research Disagree About Hybrid Work. Why?
Companies like Amazon have required a return to the office five days a week despite findings showing benefits to employers that allow some remote days.
Mortgage costs 'unlikely' to return to low levels
The boss of the UK's biggest lender says mortgage costs are unlikely to fall to levels seen in the past decade.
Budget rule change could mean more money to build hospitals
Here is how the chancellor could choose to tweak the government's borrowing rules to free up more cash.
Port plan to go ahead after row over minister's comments
A £1bn investment will take place, despite a row with the owner of P&O Ferries, says the business secretary.
Why Millennials Prioritize Spending Money to Improve Their Lives
Placing a high value on personal growth, millennials and Gen Z appear more likely than older generations to make hobbies and nonessential purchases a spending priority.
Work Advice: How Can I Get My Male Boss to Notice Me?
When there are men in the room, a female colleague is made to feel invisible.
Filmed in New York, Hold the Taxis and Radiators
When independent movies like “Rosemead” travel to a state for tax incentives, they save money but add creative challenges.
China's consumer prices rose moderately in September
China's consumer prices rose moderately in September. Experts say that market demand is set to rise following the introduction of powerful new policies aimed at stimulating the economy.
California Rejects Bid for More Frequent SpaceX Launches
A commission denied a request to increase the number of rocket launches on the state’s central coast, citing environmental concerns.
Fitch Ratings Issues Warning About France’s Finances
A rating agency’s warning about the country’s ballooning debt comes as the prime minister tries to push an austerity budget through a divided Parliament.
Led by Believers in the City’s Future, Detroit Is on the Rebound
Once the largest city in the U.S. to declare bankruptcy, this Midwestern metropolis is now thriving. But some obstacles still remain.
China stimulus policy blueprint shows passion, patience & perseverance
China's economic policy shift can be viewed through three keywords: passion, patience and perseverance.
P&O owner to attend summit despite row over minister's comments
It had been feared they might pull out after Transport Secretary Louise Haigh criticised the ferry firm and urged consumers to boycott the company.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.